Note: Nothing in our article is to be taken as providing
medical advice or recommending or endorsing the use of the drugs
mentioned below for any purpose.
Special measures have been passed in Australia which exempt
specified treatments for COVID-19 from requirements to be
registered on the Australian Register of Therapeutic Goods
(ARTG) prior to their supply.
Generally speaking (and subject to a number of special
arrangements), registration of pharmaceuticals, medical devices and
other therapeutic goods on the ARTG is a pre-requisite to the
lawful supply of those registered goods in Australia for the
indications specified in the ARTG listing. ARTG registration
follows a rigorous assessment of the goods by the Therapeutic Goods
Administration. For a drug to be approved and registered,
data demonstrating the safety and efficacy of that drug for a
particular condition or disease is required, and that data is
typically obtained by carrying out phase 3 (large-scale)